Related Experiment Videos
Hapten-specific carrier-dependent tolerance induction in man in vitro
Cellular Immunology
|December 1, 1983
Summary
Researchers induced hapten-specific tolerance in human lymphocytes in vitro. This immune tolerance, involving T and B cells, was specific to the dinitrophenyl-human gamma-globulin conjugate, suggesting therapeutic potential.
Area of Science:
- Immunology
- Cell Biology
Background:
- Inducing immune tolerance is crucial for treating autoimmune diseases.
- Understanding the cellular mechanisms of tolerance in humans is essential for developing targeted therapies.
Purpose of the Study:
- To investigate the induction of hapten-specific tolerance in cultured human lymphocytes in vitro.
- To examine the cellular basis and specificity of this induced tolerance.
Main Methods:
- Human peripheral blood lymphocytes (T and B cells) were cultured with hapten-carrier conjugates.
- Challenge with dinitrophenyl (DNP) linked to keyhole limpet hemocyanin.
- Hapten-specific antibody production was measured using solid-phase radioimmunoassay.
Main Results:
- Hapten-specific tolerance was successfully induced using dinitrophenyl conjugated to human gamma-globulin (DNP-HGG).
- Tolerance was not induced by DNP conjugates with nonhuman gamma-globulin or human serum albumin.
- Both T cells and B cells were found to be involved in the induction of tolerance to DNP-HGG.
Conclusions:
- Hapten-specific tolerance can be induced in human lymphocytes in vitro.
- The induction of tolerance is carrier-dependent and involves both T and B cells.
- This in vitro model holds significance for developing specific therapies for autoimmune diseases.